Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Am J Physiol Renal Physiol
2012 Aug 15;3034:F527-39. doi: 10.1152/ajprenal.00134.2012.
Show Gene links
Show Anatomy links
Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.
Witkowska K
,
Smith KM
,
Yao SY
,
Ng AM
,
O'Neill D
,
Karpinski E
,
Young JD
,
Cheeseman CI
.
???displayArticle.abstract???
Human SLC2A9 (GLUT9) is a novel high-capacity urate transporter belonging to the facilitated glucose transporter family. In the present study, heterologous expression in Xenopus oocytes has allowed us to undertake an in-depth radiotracer flux and electrophysiological study of urate transport mediated by both isoforms of SLC2A9 (a and b). Addition of urate to SLC2A9-producing oocytes generated outward currents, indicating electrogenic transport. Urate transport by SLC2A9 was voltage dependent and independent of the Na(+) transmembrane gradient. Urate-induced outward currents were affected by the extracellular concentration of Cl(-), but there was no evidence for exchange of the two anions. [(14)C]urate flux studies under non-voltage-clamped conditions demonstrated symmetry of influx and efflux, suggesting that SLC2A9 functions in urate efflux driven primarily by the electrochemical gradient of the cell. Urate uptake in the presence of intracellular hexoses showed marked differences between the two isoforms, suggesting functional differences between the two splice variants. Finally, the permeant selectivity of SLC2A9 was examined by testing the ability to transport a panel of radiolabeled purine and pyrimidine nucleobases. SLC2A9 mediated the uptake of adenine in addition to urate, but did not function as a generalized nucleobase transporter. The differential expression pattern of the two isoforms of SLC2A9 in the human kidney's proximal convoluted tubule and its electrogenic transport of urate suggest that these transporters play key roles in the regulation of plasma urate levels and are therefore potentially important participants in hyperuricemia and hypouricemia.
Anzai,
New insights into renal transport of urate.
2007, Pubmed
Anzai,
New insights into renal transport of urate.
2007,
Pubmed
Anzai,
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
2008,
Pubmed
,
Xenbase
Augustin,
Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking.
2004,
Pubmed
,
Xenbase
Bannasch,
Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog.
2008,
Pubmed
Bibert,
Mouse GLUT9: evidences for a urate uniporter.
2009,
Pubmed
,
Xenbase
Blom,
Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.
1999,
Pubmed
Bo,
Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes.
2001,
Pubmed
Brandstätter,
Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI.
2008,
Pubmed
Caulfield,
SLC2A9 is a high-capacity urate transporter in humans.
2008,
Pubmed
,
Xenbase
Dehghan,
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.
2008,
Pubmed
Doblado,
Facilitative glucose transporter 9, a unique hexose and urate transporter.
2009,
Pubmed
Döring,
SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.
2008,
Pubmed
Endou,
Urate transport across the apical membrane of renal proximal tubules.
2008,
Pubmed
Enomoto,
Molecular identification of a renal urate anion exchanger that regulates blood urate levels.
2002,
Pubmed
,
Xenbase
Feig,
Uric acid and hypertension.
2006,
Pubmed
Hediger,
Molecular physiology of urate transport.
2005,
Pubmed
Hjortnaes,
Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.
2007,
Pubmed
Johnson,
Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society?
2009,
Pubmed
Jutabha,
Functional analysis of human sodium-phosphate transporter 4 (NPT4/SLC17A3) polymorphisms.
2011,
Pubmed
,
Xenbase
Jutabha,
Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule.
2003,
Pubmed
,
Xenbase
Kolz,
Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.
2009,
Pubmed
Kusuhara,
In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.
2009,
Pubmed
Le,
SLC2A9--a fructose transporter identified as a novel uric acid transporter.
2008,
Pubmed
Leal-Pinto,
Molecular cloning and functional reconstitution of a urate transporter/channel.
1997,
Pubmed
Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase
Marangella,
Uric acid elimination in the urine. Pathophysiological implications.
2005,
Pubmed
Matsuo,
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.
2008,
Pubmed
Miller,
Dietary fructose and the metabolic syndrome.
2008,
Pubmed
Onat,
Serum uric acid is a determinant of metabolic syndrome in a population-based study.
2006,
Pubmed
Panoulas,
Association of serum uric acid with cardiovascular disease in rheumatoid arthritis.
2007,
Pubmed
Preitner,
Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy.
2009,
Pubmed
Rathmann,
Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study.
2007,
Pubmed
Sautin,
Uric acid: the oxidant-antioxidant paradox.
2008,
Pubmed
Shayeghi,
Nucleobase transport in opossum kidney epithelial cells and Xenopus laevis oocytes: the characterisation, structure-activity relationship of uracil analogues and oocyte expression studies of sodium-dependent and -independent hypoxanthine uptake.
1999,
Pubmed
,
Xenbase
Stark,
Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.
2008,
Pubmed
Van Aubel,
Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites.
2005,
Pubmed
Vitart,
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.
2008,
Pubmed
,
Xenbase
Wallace,
Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.
2008,
Pubmed
Weber,
Endogenous D-glucose transport in oocytes of Xenopus laevis.
1989,
Pubmed
,
Xenbase
Weber,
Comparison of a Na+/D-glucose cotransporter from rat intestine expressed in oocytes of Xenopus laevis with the endogenous cotransporter.
1991,
Pubmed
,
Xenbase
Woodward,
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
2009,
Pubmed
,
Xenbase
Yu,
Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs.
2007,
Pubmed
